The state of depression treatments today – Dr David Erritzoe

What is the state of depression treatment like today? We asked Dr. David Erritzoe, Consultant Psychiatrist and Chief Investigator of Small Pharma’s Phase I/IIa Study, Imperial College London, for his thoughts.

Dr. David Erritzoe has worked with many patients throughout his career. He shares key observations on current treatments for depression from a clinical perspective, and why the need to find alternative solutions is so important.

About Small Pharma

We’re a biotechnology company researching and developing short-acting psychedelics with supportive therapy for mental health conditions.

Register for Company Updates

    Corporate Presentation

    Follow us: